Literature DB >> 19838119

Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.

Hye Jin Yoo1, Jeong Min Lee, Jae Young Lee, Se Hyung Kim, Soo Jin Kim, Joon Koo Han, Byung Ihn Choi.   

Abstract

OBJECTIVES: The purpose of this study is to determine whether adding superparamagnetic iron oxide (SPIO)-enhanced MR images to the 2 dynamic imaging modalities, triphasic CT scan and dynamic MR imaging (MRI), improves the diagnosis of hepatocellular carcinomas (HCCs) compared with the noninvasive diagnosis provided by the European Society of Study of the Liver (EASL) criteria.
MATERIALS AND METHODS: This retrospective study included 108 patients with 152 histologically confirmed hepatocellular nodules, ie, 28 dysplastic nodules and 124 HCCs. Of the 124 HCCs, 79 were larger than 2 cm in diameter, 34 were between 1 to 2 cm, and 11 were less than 1 cm. The reviewers retrospectively analyzed by consensus the hypervascularity of the nodules on both dynamic CT and MR images as well as their signal intensity on SPIO-enhanced images. Sensitivity, specificity, and diagnostic accuracy were assessed based on the EASL noninvasive diagnostic criteria for HCC and SPIO-combined EASL criteria.
RESULTS: Seventeen (14%) of 124 HCCs were hypovascular HCC according to both imaging modalities, and hypovascular HCC was more frequently seen in the subgroup of HCC < or = 2 cm in diameter. A significant improvement in the sensitivity (78% to 96%) for diagnosing HCCs larger than 2 cm in diameter, was achieved by adding SPIO-enhanced MR images to 2 dynamic studies compared with the noninvasive diagnosis according to the EASL criteria (P < 0.01). When the EASL criteria were applied to the 34 HCCs of 1 to 2 cm in diameter, 21 lesions (62%) were correctly diagnosed using the EASL criteria and 29 lesions (85%) according to the SPIO-combined EASL criteria.
CONCLUSIONS: Adding SPIO-enhanced MR images to the dynamic imaging modalities, including triphasic CT and dynamic MRI, improves the noninvasive diagnosis of HCCs compared with using only the EASL criteria, especially when attempting to diagnose hypovascular or slightly hypervascular HCCs. As these images combine information regarding the function or deficit of Kupffer cells within the hepatic nodules with vascularity information, combining sequentially acquired SPIO-enhanced MRI with dynamic MRI could be considered to be the single-step imaging modality with a high degree of accuracy in the diagnostic work-up of small HCCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19838119     DOI: 10.1097/RLI.0b013e3181bc271d

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  10 in total

Review 1.  Superparamagnetic iron oxide-enhanced magnetic resonance imaging for focal hepatic lesions: systematic review and meta-analysis.

Authors:  You-Wei Li; Zheng-Guang Chen; Ji-Chen Wang; Zong-Ming Zhang
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

Review 2.  New paradigm for management of hepatocellular carcinoma by imaging.

Authors:  Ijin Joo; Byung Ihn Choi
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

Review 3.  Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.

Authors:  An Tang; Mustafa R Bashir; Michael T Corwin; Irene Cruite; Christoph F Dietrich; Richard K G Do; Eric C Ehman; Kathryn J Fowler; Hero K Hussain; Reena C Jha; Adib R Karam; Adrija Mamidipalli; Robert M Marks; Donald G Mitchell; Tara A Morgan; Michael A Ohliger; Amol Shah; Kim-Nhien Vu; Claude B Sirlin
Journal:  Radiology       Date:  2017-11-21       Impact factor: 11.105

4.  Negatively charged superparamagnetic iron oxide nanoparticles: a new blood-pooling magnetic resonance contrast agent.

Authors:  Norihisa Nitta; Keiko Tsuchiya; Akinaga Sonoda; Shinichi Ota; Noritoshi Ushio; Masashi Takahashi; Kiyoshi Murata; Satoshi Nohara
Journal:  Jpn J Radiol       Date:  2012-09-22       Impact factor: 2.374

Review 5.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

Review 6.  Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.

Authors:  Victoria Chernyak; Kathryn J Fowler; Aya Kamaya; Ania Z Kielar; Khaled M Elsayes; Mustafa R Bashir; Yuko Kono; Richard K Do; Donald G Mitchell; Amit G Singal; An Tang; Claude B Sirlin
Journal:  Radiology       Date:  2018-09-25       Impact factor: 11.105

7.  APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review.

Authors:  Cher Heng Tan; Su-Chong Albert Low; Choon Hua Thng
Journal:  Int J Hepatol       Date:  2011-04-19

Review 8.  Diagnostic value of imaging examinations in patients with primary hepatocellular carcinoma.

Authors:  Xing-Hui Li; Qi Liang; Tian-Wu Chen; Jian Wang; Xiao-Ming Zhang
Journal:  World J Clin Cases       Date:  2018-09-06       Impact factor: 1.337

Review 9.  Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring.

Authors:  Tiffany Hennedige; Sudhakar Kundapur Venkatesh
Journal:  Cancer Imaging       Date:  2013-02-08       Impact factor: 3.909

Review 10.  Overall diagnostic accuracy of different MR imaging sequences for detection of dysplastic nodules: a systematic review and meta-analysis.

Authors:  Jingtong Xiong; Jiawen Luo; Jie Bian; Jianlin Wu
Journal:  Eur Radiol       Date:  2021-08-06       Impact factor: 5.315

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.